TriSalus Life Sciences Lowers FY2026 Sales Guidance from $60.000M-$62.000M to $54.000M-$57.000M vs $59.960M Est

Benzinga Newsdesk www.benzinga.com Negative 96.1%

Neg 96.1% Neu 0% Pos 0%

TriSalus Life Sciences (NASDAQ:TLSI) lowers FY2026 sales outlook from $60.000 million-$62.000 million to $54.000 million-$57.000 million vs $59.960 million estimate.